Roles of Pharmacists for Realizing the Sustainability of the Aging Society

DOI Web Site
  • TAKAMURA Kento
    大阪大学大学院 薬学研究科 附属創薬センター 医薬品・医療機器規制科学
  • SUZUKI Nobutoshi
    大阪大学大学院 薬学研究科 附属創薬センター 医薬品・医療機器規制科学
  • TACHIBANA Keisuke
    大阪大学大学院 薬学研究科 附属創薬センター 医薬品・医療機器規制科学
  • KONDOH Masuo
    大阪大学大学院 薬学研究科 附属創薬センター 医薬品・医療機器規制科学

Bibliographic Information

Other Title
  • 少子高齢化社会を見据えた社会保障のエコシステムにおける病院・薬局薬剤師の役割に関する考察
  • ショウシ コウレイカ シャカイ オ ミスエタ シャカイ ホショウ ノ エコ システム ニ オケル ビョウイン ・ ヤッキョク ヤクザイシ ノ ヤクワリ ニ カンスル コウサツ

Search this article

Description

<p>Japan’s population is rapidly declining and the aged population will predominate within 20 years. Therefore, maintaining a strong financial, health and welfare is an urgent issue. Japan’s population will continue to decrease, and the number of elderly people will reach its peak around 2040. By 2040, the total population is expected to decrease to 110.92 million, with 1.4 productive age persons per elderly person. In addition, the national medical care expenditure, which is part of the social security benefits, is expected to increase approximately 1.7 times, from 39.2 trillion yen in fiscal year (FY) 2018 to 66.7 to 68.5 trillion yen in FY2040. In recent years, innovative drugs have been developed and approved for patient care, and the use of these expensive drugs has increased medical costs. In general, the prices of new pharmaceuticals without similar drugs are calculated by the cost accounting system on the basis of manufacturing costs, sales costs, research costs, distribution costs, and so on. In this review, we consider how pharmacists contribute to reducing medical costs to ensure the sustainability of the aging society, focusing on the cost structure of pharmaceutical companies in the drug pricing system in Japan.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top